| Line 7: |
Line 7: |
| | | | |
| | In June, 2010, a team including Shi Zhengli, published a paper. It described research to understand the susceptibility of angiotensin converting enzyme 2 ACE-2 proteins, of different bat species to the S Protein of the SARS virus. In the experiments, they also modified key amino acid codons to mutate the bats ACE-2 to examine compatibility with the SARS S Protein. This paper demonstrated their awareness of the special relationship between the S Protein and the [[ACE-2]] receptor. It also signified that Shi had unearthed the passageway for coronaviruses into human bodies. | | In June, 2010, a team including Shi Zhengli, published a paper. It described research to understand the susceptibility of angiotensin converting enzyme 2 ACE-2 proteins, of different bat species to the S Protein of the SARS virus. In the experiments, they also modified key amino acid codons to mutate the bats ACE-2 to examine compatibility with the SARS S Protein. This paper demonstrated their awareness of the special relationship between the S Protein and the [[ACE-2]] receptor. It also signified that Shi had unearthed the passageway for coronaviruses into human bodies. |
| − | {|class="infobox" style="float:right; font-size:85%; width:1ex; line-height:17px; margin: 0px 0px 5px 50px" cellpadding="1" | + | [[File:USAID.png||right|thumb|250px|''Source:'' sharylatkisson.com<ref>https://sharylattkisson.com/2021/06/video-exclusive-investigation-separating-rumor-from-fact-on-covid-19s-origin/</ref>]] |
| | + | In October, 2013, Shi and her team published a paper in ''Nature''. They claimed a breakthrough in coronavirus research. They successfully isolated three viruses from bats, one of which had a S Protein that integrated with human ACE-2 receptors. This effectively demonstrated the direct human infection of SARS-like viruses to humans, without the need of an intermediate host. |
| | + | {|class="infobox" style="float:left; font-size:85%; width:1ex; line-height:17px; margin: 0px 0px 5px 50px" cellpadding="1" |
| | |[[File:Shi Zhengli 2.PNG|208px]] | | |[[File:Shi Zhengli 2.PNG|208px]] |
| | |[[File:Ralph Baric.jpg|198px]] | | |[[File:Ralph Baric.jpg|198px]] |
| Line 13: |
Line 15: |
| | |colspan="3"|<hr/>Left:Shi Zhengli; Right:Ralph Baric. | | |colspan="3"|<hr/>Left:Shi Zhengli; Right:Ralph Baric. |
| | |} | | |} |
| − | In October, 2013, Shi and her team published a paper in ''Nature''. They claimed a breakthrough in coronavirus research. They successfully isolated three viruses from bats, one of which had a S Protein that integrated with human ACE-2 receptors. This effectively demonstrated the direct human infection of SARS-like viruses to humans, without the need of an intermediate host.
| |
| − | [[File:USAID.png||left|thumb|250px|''Source:'' sharylatkisson.com<ref>https://sharylattkisson.com/2021/06/video-exclusive-investigation-separating-rumor-from-fact-on-covid-19s-origin/</ref>]]
| |
| | Then in November, 2015, Shi and her team at the Wuhan virology lab once again published a paper. This time in the British journal, ''Nature Medicine''.<ref>https://www.nature.com/articles/nm.3985</ref> They discussed the creation of a synthetic virus, a self-replicating Chimeric virus. This virus had the SARS virus as the framework, with the key S protein replaced, by the one they had found in a bat coronavirus, she mentioned in her 2013 paper. This new virus demonstrated a powerful ability for cross-species infection. | | Then in November, 2015, Shi and her team at the Wuhan virology lab once again published a paper. This time in the British journal, ''Nature Medicine''.<ref>https://www.nature.com/articles/nm.3985</ref> They discussed the creation of a synthetic virus, a self-replicating Chimeric virus. This virus had the SARS virus as the framework, with the key S protein replaced, by the one they had found in a bat coronavirus, she mentioned in her 2013 paper. This new virus demonstrated a powerful ability for cross-species infection. |
| | | | |